ritonavir

Topline safety, antiviral effectiveness and pharmacokinetic (PK) data from a Phase 1b Study in China are released from the single ascending dose (SAD) portion of the study with the doses…

Elana Gotkine MONDAY, Dec. 12, 2022 (HealthDay News) -- Nirmatrelvir plus ritonavir reduces the risk for hospitalization or death after an outpatient…

Topline safety and pharmacokinetic (PK) data from the Phase I single ascending dose (SAD)/multiple ascending dose (MAD) study of STI-1558 in 58 healthy volunteers in Australia are now…

Note that some links may require registration or subscription. Moderna said its…

The development of oral COVID-19 antivirals such as nirmatrelvir/ritonavir (Paxlovid) was nothing…

Oral antiviral treatment for COVID-19 is now on the table following FDA's emergency use…

Ritonavir (PF-07321332), an investigational oral antiviral, cut COVID-related hospitalizations…

Proponents of ivermectin for COVID-19 have long been talking about an expected review and…